Molecular Controls for Emerging Diseases: the Need for Rapid Development & Harmonization
The COVID-19 pandemic put a spotlight on the need for expedited development of molecular controls that can standardize results of the myriad tests created to accurately diagnose emerging diseases. Armored Molecular Controls* are synthetic, non-infectious, non-biological, ribonuclease-resistant full process controls that can be quickly designed and scaled to meet global supply demands. Learn how Armored Molecular Controls* have been deployed to harmonize SARS-CoV-2 assays and rapidly developed to address the Monkeypox outbreak, as well as their application in wastewater surveillance for emerging diseases.
*For Research Use Only. Not For Use in Diagnostic Procedures.